Shanthi Rexaline

Shanthi is a contributor to InvestorPlace.com and works as a Staff Writer with Benzinga. Equipped with a Bachelor’s degree in Agriculture and an MBA with specialization in finance and marketing, she has about two decades of experience in financial reporting and analysis, and specializes in the biopharma and EV sectors.

Recent Articles

Lucid Could Take Investors on a Rough Ride Near Term

By Shanthi Rexaline

Lucid flagged production issues and tempered its outlook for 2022. It remains to be seen if LCID stock can overcome the near-term issues.

Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock

By Shanthi Rexaline

Moderna has to focus on the rest of its pipeline to keep MRNA stock relevant and profitable as Covid vaccine revenues taper off by 2023.

Alibaba Stock Looks Cheap Here for a Long-Term Buyer

By Shanthi Rexaline

BABA stock has caused so much frustration to investors, but today's weakness could be an excellent entry point for long-term Alibaba growth.

Bitcoin Is Priming for a Long-Term Breakout

By Shanthi Rexaline

Bitcoin has been locked in a lackluster phase since late last year. But the long-term factors are on its side, and it should grow further.

Apple Is Poised for Big Gains Amid Spring Hardware Launches

By Shanthi Rexaline

AAPL stock could defy the typically slower first half and launch into rally, thanks to plenty of new tech on tap.

Load More